Alfresa Holdings (2784) · InitiativeFirst stated
Support for antibody drug R&D and enhancement of manufacturing technology
First written in FY2024-Q1. . Latest entry: FY2024-Q1.
1entries
1years
0from disclosures
How it moved
Same theme, other companies
Strengthening the R&D Foundation Through External Collaboration and Advanced TechnologiesA theme 60 companies write about · 0 as a headwind · 62 as a tailwind
5 other companies' latest entry also says "First stated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 60 companies compared. The sentences above are computed from all 60.